FR2802421A1 - Cosmetic oil-in-water emulsion creams containing aqueous placenta extract for the treatment of heat-sensitive skin - Google Patents
Cosmetic oil-in-water emulsion creams containing aqueous placenta extract for the treatment of heat-sensitive skin Download PDFInfo
- Publication number
- FR2802421A1 FR2802421A1 FR0006472A FR0006472A FR2802421A1 FR 2802421 A1 FR2802421 A1 FR 2802421A1 FR 0006472 A FR0006472 A FR 0006472A FR 0006472 A FR0006472 A FR 0006472A FR 2802421 A1 FR2802421 A1 FR 2802421A1
- Authority
- FR
- France
- Prior art keywords
- weight
- rtm
- minutes
- concentration
- cream
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims description 9
- 239000000284 extract Substances 0.000 title claims description 8
- 239000006071 cream Substances 0.000 title description 18
- 210000002826 placenta Anatomy 0.000 title description 2
- 239000007764 o/w emulsion Substances 0.000 title 1
- 230000037307 sensitive skin Effects 0.000 title 1
- 239000004480 active ingredient Substances 0.000 claims description 15
- 239000000839 emulsion Substances 0.000 claims description 11
- 239000012071 phase Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000008346 aqueous phase Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 6
- 230000003020 moisturizing effect Effects 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 235000005979 Citrus limon Nutrition 0.000 claims description 4
- 244000131522 Citrus pyriformis Species 0.000 claims description 4
- 241001440269 Cutina Species 0.000 claims description 4
- 230000003712 anti-aging effect Effects 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- 230000003169 placental effect Effects 0.000 claims description 3
- 230000001153 anti-wrinkle effect Effects 0.000 claims description 2
- 239000003899 bactericide agent Substances 0.000 claims description 2
- 239000013256 coordination polymer Substances 0.000 claims description 2
- 239000012153 distilled water Substances 0.000 claims description 2
- 230000000855 fungicidal effect Effects 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000002304 perfume Substances 0.000 claims description 2
- INLFWQCRAJUDCR-IQVMEADQSA-N (1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane] Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CCCCC4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 INLFWQCRAJUDCR-IQVMEADQSA-N 0.000 claims 2
- 238000013019 agitation Methods 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 239000000417 fungicide Substances 0.000 claims 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 11
- 239000002253 acid Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 241000208983 Arnica Species 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 208000003217 Tetany Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 238000005899 aromatization reaction Methods 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- -1 cetyl ester Chemical class 0.000 description 2
- 239000008845 cholagoga Substances 0.000 description 2
- 229940124571 cholagogue Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical group CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- WEYVVCKOOFYHRW-UHFFFAOYSA-N usnic acid Chemical compound CC12C(=O)C(C(=O)C)=C(O)C=C1OC1=C2C(O)=C(C)C(O)=C1C(C)=O WEYVVCKOOFYHRW-UHFFFAOYSA-N 0.000 description 2
- 239000005526 vasoconstrictor agent Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- RPWFJAMTCNSJKK-UHFFFAOYSA-N Dodecyl gallate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1 RPWFJAMTCNSJKK-UHFFFAOYSA-N 0.000 description 1
- 101100186820 Drosophila melanogaster sicily gene Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229930185210 Saponoside Natural products 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 240000002493 Smilax officinalis Species 0.000 description 1
- 235000008981 Smilax officinalis Nutrition 0.000 description 1
- 241001441361 Usnea barbata Species 0.000 description 1
- 206010047141 Vasodilatation Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000656 anti-yeast Effects 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000003822 cell turnover Effects 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000000555 dodecyl gallate Substances 0.000 description 1
- 229940080643 dodecyl gallate Drugs 0.000 description 1
- 235000010386 dodecyl gallate Nutrition 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 235000010181 horse chestnut Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000037306 mature skin Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Chemical class 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 239000012875 nonionic emulsifier Substances 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 150000002943 palmitic acids Chemical class 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000011252 protective cream Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 229940004858 usnic acid Drugs 0.000 description 1
- ICTZCAHDGHPRQR-UHFFFAOYSA-N usnic acid Natural products OC1=C(C)C(O)=C(C(C)=O)C2=C1C1(C)C(O)=C(C(=O)C)C(=O)C=C1O2 ICTZCAHDGHPRQR-UHFFFAOYSA-N 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/982—Reproductive organs; Embryos, Eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Reproductive Health (AREA)
- Zoology (AREA)
- Cosmetics (AREA)
Abstract
Description
La présente invention concerne une crème cosmétique hydratante, anti- inflammatoire, anti-vieillissement et son procédé de fabrication pour les soins du visage et des mains, destinée aux personnes sensibles aux sources de chaleur par rayonnement infrarouge. Tous les composants de cette crème sont des composants brevetés. The present invention relates to a moisturizing, anti-inflammatory, anti-aging cosmetic cream and its method of manufacture for the care of the face and hands, intended for persons sensitive to heat sources by infrared radiation. All components of this cream are patented components.
Les qualités de surface qui sont concernées par cette crème sont : les peaux sèches et mâtes (la peau ne luit pas), ayant l' aspect graveleuses (cratère) ; les peaux irritées par les infrarouges (peau rougeâtre) ; les peaux vieilles (rides). The surface qualities which are concerned by this cream are: dry and mature skins (the skin does not shine), having the gravelly aspect (crater); skin irritated by infrared (reddish skin); old skin (wrinkles).
les fonctions des principes actifs font de cette crème, une crème hydratante et protectrice apportant souplesse à la peau ; crème anti-vieillissement par l'amélioration de la micro-circulation; crème anti-inflammatoire protectrice des sources de chaleur d' origines infrarouge. the functions of the active ingredients make this cream, a moisturizing and protective cream providing suppleness to the skin; anti-aging cream by improving micro-circulation; protective anti-inflammatory cream of heat sources of infrared origins.
Les personnes concernées sont les personnes ayant la peau du<I>visage</I> et des mains et autres parties du corps (les bras) exposée à des sources de chaleur de moyenne et haute température ( four de cuisson, les hauts fourneaux, les chauffages, les lessives à la main dans l' eau chaude, les personnes du corps médical ayant la peau très sensible au désinfectant, etc...). The persons concerned are persons with the skin of the face and hands and other parts of the body (the arms) exposed to medium and high temperature heat sources (baking oven, blast furnaces, heaters, laundry by hand in hot water, medical staff with skin very sensitive to disinfectant, etc ...).
L' innovation dans cette crème réside dans les principes actifs utilisés et réunis ensemble au nombre de trois- Un tonifiant de l' acide hyaluronique, un tonifiant du collagène, un tonifiant de l' A D 1V. Des acides de fruits, de la vitamine A acide, vitamines C et E, des caroténoides et du sélénium. The innovation in this cream lies in the active ingredients used and gathered together in three - A tonic of hyaluronic acid, a tonic of collagen, a tonic of A D 1V. Fruit acids, vitamin A acid, vitamins C and E, carotenoids and selenium.
La chaleur est synonyme de desydratation. Si la source de chaleur provient d' une origine infrarouge, il y a vasodilatation, ce qui entraîne un apport de sang trop important et peut provoquer des érythèmes (rougeur de la peau). Cela correspond à une brûlure du premier degré. Heat is synonymous with dehydration. If the source of heat is of an infra - red origin, there is vasodilatation, resulting in excessive blood supply and may cause erythema (redness of the skin). This corresponds to a first degree burn.
Le procédé de traitement de tels cas de peau et l' utilisation d' un vaso- constricteur (astringent) et l' utilisation de l' acide de fruit dont les acides végétaux qui entraînent la. desquamation et l'élimination des cellules mortes sur la couche superficielle de l'épiderme. Ils augmentent le renouvellement cellulaire, donc l'épaisseur de l'épiderme. Ils ont aussi un effet hydratant et régénèrent l' élastine puis renforcent le collagène. The method of treating such skin cases and the use of a vasoconstrictor (astringent) and the use of the fruit acid of which the plant acids which cause the. desquamation and removal of dead cells on the superficial layer of the epidermis. They increase cell turnover, so the thickness of the epidermis. They also have a moisturizing effect and regenerate the elastin and strengthen the collagen.
Tous les pourcentages sont sur la base du poids total. All percentages are based on total weight.
La phase acqueuse pour l' émulsion est de l' eau traitée par distillation dont le qsp varie de<B>60</B> e!o à 80 lo en poids par rapport au poids total et dont la concentration est de 52 fo en poids, ce qui donne une masse d' eau supérieure à'A . The aqueous phase for the emulsion is distilled water whose qsp varies from <B> 60% to 80% by weight relative to the total weight and whose concentration is 52%. weight, which gives a mass of water greater than A.
La phase grasse caractérisée par trois acides gras a, b, c, en fait une phase grasse de qualité particulièrement excellente a) Le M1ERffOL 0 31$ qui est une composition triglycéride d' acide caprylique l capnque, est une huile neutre, claire, inodore, presque incolore et de faible viscosité. Le MERITOL <B>318</B> est un triglycéride d' acides gras végétaux saturés de premier choix qui conviennent particulièrement aux corps huileux de ce type. Grâce à sa composition chimique et son caractère neutre, il est un composant huileux très dermatophile. Sa densité varie de 0,945 à Q,949 glcm3 à 20 C. The fatty phase characterized by three fatty acids a, b, c, makes it a fatty phase of particularly excellent quality a) M1ERffOL 0 31 $ which is a triglyceride composition of caprylic acid l capnque, is a neutral, clear, odorless oil , almost colorless and of low viscosity. MERITOL <B> 318 </ B> is a triglyceride of saturated vegetable fatty acids of first choice which is particularly suitable for oily bodies of this type. Due to its chemical composition and neutral character, it is a very dermatophilic oily component. Its density varies from 0.945 to 949 g / cm3 at 20 ° C.
b) L' EUMULGIN BI qui est un alcool cétylénique stéarilique avec environ 12 moles d' EG. Ses propriétés en font un émulsifiant non-ionique pour des émulsions très finement dispersées. II est spécialement approprié pour des substances difficiles à émulsionner ou celles qui sont inaptes à l'émulsion. b) EUMULGIN BI which is a stearyl cetylenic alcohol with about 12 moles of EG. Its properties make it a non-ionic emulsifier for very finely dispersed emulsions. It is especially suitable for substances which are difficult to emulsify or which are not suitable for emulsification.
Son pouvoir émulsifiant sert dans des préparations cosmétiques ou pharmaceutiques peu visqueuses et consistantes du type M qui sont utilisées de préférence pour des émulsions liquides à semi-liquides. Sa densité varie de 0,969 à 0;972 à<B>70`</B> C. Its emulsifying power is used in low viscosity and consistent type M cosmetic or pharmaceutical preparations which are preferably used for liquid to semi-liquid emulsions. Its density ranges from 0.969 to 0; 972 to <B> 70` C.
c) Le CUTINA - CP@ qui est un ester d' alcools gras à longues chaînes saturées et d' acides gras, notamment de cetylester d' acides palmitiques (Palmitate Cétylique). Sa densité varie de 0,817 à 0,820. c) CUTINA - CP @, which is an ester of fatty alcohols with saturated long chains and of fatty acids, in particular cetyl ester of palmitic acids (cetyl Palmitate). Its density varies from 0.817 to 0.820.
En tant que facteur de consistance, le CUTINA - CP convient aux préparations cosmétiques et pharmaceutiques sous formes d'émulsions telles que les crèmes, les pommades, les produits de maquillage gras et les préparations en forme de stick. As a consistency factor, CUTINA - CP is suitable for cosmetic and pharmaceutical preparations in the form of emulsions such as creams, ointments, oily make - up products and stick - shaped preparations.
Les concentrations respectives des principes actifs a, b, c sont d' environ de 1 %à10%enpoids,de0,3%à3%enpoids,del,5%à 15%enpoids. The respective concentrations of the active ingredients a, b, c are from about 1% to 10% by weight, from 0.3% to 3% by weight, and from 5% to 15% by weight.
Le principe actif global caractérisé par trois principes actifs A,<B>B, B',</B> C, réunit les qualités primaires, les qualités secondaires et tertiaire de cette crème. A) L'EXTRAIT PLACENTAIRE ACQUEUX - EPA40 est un principe actif à base de placentas humain Il subit un traitement permettant l' initiation et la hibération complète des principes actifs solubles (biostimulines). The active ingredient, characterized by three active ingredients A, <B> B, B ', </ B> C, combines the primary qualities, the secondary and tertiary qualities of this cream. A) PLACENTAL EXTRACT ACQUEUX - EPA40 is an active ingredient based on human placentas It undergoes a treatment allowing the initiation and the complete hiberation of the soluble active principles (biostimulins).
Caractérisé par sa teneur en principes physiologiquement actifs facilement assimilables, ce principe actif apporte aux cellules cutanées tes éléments de base indispensables à l' hydratation de la peau, à la régénération cellulaire et au rajeunissement des tissus. Characterized by its content of easily assimilable physiologically active principles, this active ingredient provides cutaneous cells with the basic elements essential for skin hydration, cell regeneration and tissue rejuvenation.
Ce produit est d' aspect liquide limpide de couleur jaune avec une odeur légèrement caractéristique, de PI-I 5 à 6. Les propriétés biologiques de l' EXTRAIT PLACENTAIRE ACQUEUX- EPA40 sont liées à sa concentration en principes actifs tel que Les bïostimulines au sens de Filatov, les ensembles synergiques d' amino- acides constitutifs des a et j3 factoprotéines, les acides nucléiques, les sels- minéraux et les oligo-éléments comme Na, K, Mg, Si. This product has a clear yellow liquid appearance with a slightly characteristic odor, PI-I 5 to 6. The biological properties of the ACQUEUX-EPA40 PLACENTAL EXTRACT are related to its concentration of active ingredients such as the biotosulins in the sense of Filatov, the synergistic groups of amino acids constituting the α and β3 factoproteins, nucleic acids, mineral salts and trace elements such as Na, K, Mg, Si.
Son application s' étant dans de nombreux types de préparations cosméto- logiques ou pharmaceutiques : les produits traitants contre le vieillissement cutané (antirides, etc._); les produits de protection cutanée (après solaire_._), les produits. Its application being in many types of cosmetological or pharmaceutical preparations: the products treating skin aging (anti-wrinkles, etc.); skin protection products (after solar _._), products.
nourrissants et hydratants (présence d ` acides aminés hygroscopiques), les produits capillaires par stimulation de la micro-circulation du cuir chevelu (chute des cheveux). Ces qualités en font un bon anti-inflammatoire et -un bon antivieil- lissement tout en ayant un bon pouvoir hydratant. nourishing and moisturizing (presence of hygroscopic amino acids), hair products by stimulating the micro-circulation of the scalp (hair loss). These qualities make it a good anti-inflammatory and a good anti-aging while having a good moisturizing power.
B) Un Bactériostatique DROGUES A SAPONOSIDES <B>1</B> RI<B>1</B> ERFIENIQUES (triterpénes pentacycliques). II a une activité antimicrobienne et antifongique (lierre Henderagénine) et une activité anti-inflammatoire ainsi qu' une activité anti-oedémateuse (Marron d' Inde : escine ; Réglisse : acide glycerihéblique). B) Bacteriostatic DRUGS WITH SAPONOSIDES <B> 1 </ B> RI <B> 1 </ B> ERFIENIC (pentacyclic triterpenes). It has antimicrobial and antifungal activity (ivy Henderagenine) and anti-inflammatory activity as well as anti-oedematous activity (Horse chestnut: escine, licorice: glyceriblique acid).
B') Entrant dans la catégorie du second principe actif on a aussi utilisé de la SAPOGENINES STEROÏDIQUES qui est un anti-inflammatoire, un vaso- constricteur périphérique utilisé en phlébologie (Petit Houx<B>:</B> Ruscogéniques, Diurétique, Asperge, Salsepareille). B ') Entering into the category of the second active ingredient is also used SAPOGENINES STEROIDIC which is an anti-inflammatory, a peripheral vasoconstrictor used in phlebology (Small Holly <B>: </ B> Ruscogenic, Diuretic, Asparagus , Sarsaparilla).
C) L'utilisation d' un anti=érnostatique extrait de plantes dans un solvant glycol eau, L' HERBASOL - EXTRACT ARNICA, est un extrait de plantes non dénaturé, obtenu par un procédé spécial: L'extrait liquide et stable, facilite son utilisation en cosmétique. L'extraction à froid assure la conservation des propriétés aromatiques. C) The use of an anti - ernostatic plant extract in a water glycol solvent, HERBASOL - EXTRACT ARNICA, is an undenatured plant extract, obtained by a special process: The liquid and stable extract, facilitates its use in cosmetics. The cold extraction ensures the conservation of the aromatic properties.
Le produit de départ sont les fleurs d' Arnica (Flos Arnica). Son utilisation s'applique aux crèmes, déodorants, crèmes podologiques, préparations pour bains, crèmes dites pour le sport, traitement antipelliculaire, pâte dentifrice, bains de bouche. L'-ufilisation générale dé la plante s'étant en spasmophilie, sédatif nerveux, cholagogue (acides- polyphénoliques). Vulnérable en usage externe. Utilisable pour ses propriétés, l' Arnica est surtout populaire comme anf-ecchymotique. The starting material are Arnica flowers (Flos Arnica). Its use is applied to creams, deodorants, podiatry creams, bath preparations, so-called sports creams, anti-dandruff treatment, toothpaste, mouthwashes. The general use of the plant being in spasmophilia, nervous sedation, cholagogue (polyphenolic acids). Vulnerable in external use. Usable for its properties, Arnica is especially popular as anf-ecchymotic.
Les concentrations respectives des principes actifs A, B, B', C -sont d'environ de 0,1 % à 1 % en poids, de 0,1 % à I % en poids, de 0,3 lo à 3 % en poids et de 0,5 /e à 5 % en poids. . The respective concentrations of the active ingredients A, B, B ', C are from about 0.1% to 1% by weight, from 0.1% to 1% by weight, from 0.3% to 3% by weight. weight and from 0.5% to 5% by weight. .
Les trois critères importants d' une crème sont généralement ses principes actifs, sa couleur et son odeur. L' utilisation d' adjuvants est donc nécessaire pour l' aromatisation a, la conservation 0 et la coloration e. The three important criteria of a cream are usually its active ingredients, its color and its smell. The use of adjuvants is therefore necessary for aromatization, preservation and coloring.
Ainsi le choix d' un aromate a s' est caractérisé par l' utilisation D' ESSENCE DE CITRON ITALIE, dont la concentration varie d'environ 0,3 % à 3 % en poids. D' un aspect liquide mobile, limpide et légèrement trouble, de couleur jaune clair à jaune verdâtre et de densité variant de 0,849 à 0,858 à 20 C_ L'ESSENCE-DE-CITRON ITALIE est une huile essentielle extraite par expression à froid de la partie externe du péricarde du fruit du citron (citnzs limon, L.) cultivé en Sicile. Son utilisation sert en aromatisation, parfumerie et cosmétique (usage externe exclusivement), Produit concentré pour l' usage industriel. Thus the choice of an aromatic herb has been characterized by the use of ITALIAN LEMON ESSENCE, the concentration of which varies from about 0.3% to 3% by weight. It has a liquid, clear and slightly turbid liquid appearance, light yellow to greenish yellow in color, with a density ranging from 0.849 to 0.858 at 20 ° C. ITALIAN LEMON ESSENCE is an essential oil extracted by cold expression of the part. external pericardium of lemon fruit (citnzs limon, L.) grown in Sicily. Its use is used in aromatization, perfumery and cosmetics (external use only), concentrated product for industrial use.
Extrait de plantes non dénaturé, obtenu par un procédé spécial, cet extrait liquide est stable facilite son utilisation en cosmétique. L'extraction â froid assure la conservation des propriétés aromatiques. Le produit de départ et la fleur d' Arnica (Flos Arnica). Undenatured plant extract, obtained by a special process, this liquid extract is stable facilitates its use in cosmetics. The cold extraction ensures the conservation of the aromatic properties. The starting product and the Arnica flower (Flos Arnica).
Dans la drogue on peut signaler des polyphénoles (flavoïdes, acide caféique, chlorogénique) et de nombreux alcools terpéniques. In the drug we can report polyphenols (flavoids, caffeic acid, chlorogenic) and many terpene alcohols.
L'utilisation générale de la plante intervient dans la Spasmophilie, comme sédatif nerveux, cholagogue (acides polyphénoliques). Utilisable pour ses propriétés, l' Arnica est surtout populaire comme anti-ecchymotique. The general use of the plant is involved in Spasmophilia, as a nervous sedative, cholagogue (polyphenolic acids). Usable for its properties, Arnica is especially popular as an anti-ecchymotic.
Le choix comme agent de conservation 0 est caractérisé par un fongistatique - bactéristatique, LE DEO - USNATE, dont la concentration varie d' environ 0,3 % à 0,5 lo.C' est un extrait de plante non acqueux hautement concentré à l' action bactéricide, fongicide et anti-levure provenant de mousses alpines (usnea-barbata). La teneur en matière active est standardisée à 7,5 lo (+) usnates. - C' est donc un solvant 1,2 propylène glycol (USP). Les applications de ce bactéricide purement végétal convient pour les déodorants, les produits pour les soins des pieds, ceux pour l' hygiène de la bouche, les crèmes et les lotions spéciales. Le DUO USNATE peut également être utilisé comme composant d' agent 25 de conservation F. The choice as preservative 0 is characterized by a fungistatic - bacteriostatic, DEO - USNATE, the concentration of which ranges from about 0.3% to 0.5%. It is a highly concentrated, non - aqueous plant extract. bactericidal, fungicidal and anti-yeast action from alpine mosses (usnea-barbata). The active ingredient content is standardized to 7.5 L (+) usnates. - It is therefore a 1,2 propylene glycol solvent (USP). Applications of this pure vegetable bactericide are suitable for deodorants, foot care products, mouth hygiene products, creams and special lotions. DUO USNATE can also be used as a preservative component F.
fig. 1 : 1,2 propylène glycol (USP) formule développée de l' acide usnique
La compatibilité avec la peau est très bonne. Le dosage varie d' environ 0,3 % à environ 0,5 lo du poids total de la masse. Fig. 1: 1,2 propylene glycol (USP) developed formula of usnic acid
The compatibility with the skin is very good. The dosage ranges from about 0.3% to about 0.5% of the total weight of the mass.
L'utilisation d' un antioxydant, dans la crème, tel que LE GALLATE DE DODECYLE <B>(</B> Cly H30 Os ), dont la concentration varie d' environ 0,1 % à 0,5 %. est caractérisé par un produit d' aspect poudre cristalline et de couleur banc crème. The use of an antioxidant in cream, such as DODECYL GALLATE <B> (</ b> Cly H30 Os), the concentration of which ranges from about 0.1% to 0.5%. is characterized by a product of crystalline powder appearance and cream bench color.
Le point de fusion se situe à environ 95 - 98 C. Insoluble dans l' eau, il est légèrement soluble dans les huiles. Sa propriété est celle d' un antioxydant. Son utilisation concerne les cosmétiques et la pharmacie ( crèmes, laits, pommades, etc.j. The melting point is about 95 - 98 C. Insoluble in water, it is slightly soluble in oils. Its property is that of an antioxidant. Its use concerns cosmetics and pharmacy (creams, milks, ointments, etc.).
un agent de coloration s a été utilisé pour cette crème et participe harmonieusement à la finition de celle-ci, Il est caractérisé par un ORANGE SOLEIL W 200<B>(15985)</B> ID & C YELLOW n 6. a coloring agent has been used for this cream and harmoniously participates in the finishing of it, It is characterized by a SUN ORANGE W 200 <B> (15985) </ B> ID & C YELLOW n 6.
fig. 2 : formule chimique
Sa teneur en matière colorante pure est d' environ 70 % et son PH est compris entre 8 et 10. II à une bonne solidité aux acides et reste solide à la lumière. Sa solidité à la lumière est moyenne. La concentration en colorant varie d' environ 2,6 % à environ 26 %. Fig. 2: chemical formula
Its content of pure dyestuff is about 70% and its pH is between 8 and 10. It has good acid fastness and remains solid in the light. Its solidity to light is average. The dye concentration ranges from about 2.6% to about 26%.
la phase grasse est préparée par mélange du MERITOL 318 , de l' EITMULGIN B 1 et du CITINA - CP8, â chaud à une température de 80 C pendant 45 minutes. the fat phase is prepared by mixing MERITOL 318, EITMULGIN B 1 and CITINA-CP8, at a temperature of 80 ° C. for 45 minutes.
Le procédé de préparation est caractérisé en ce que l' émulsion de type HlE est préparée selon le procédé suivant La phase grasse et la phase acqueuse préalablement préparées sont portées- séparément à une température variant entre 80 et 90 C, puis après agitation de la phase acqueuse, on incorpore lentement la phase grasse dans la phase acqueuse_ L' agitation est poursuivie jusqu'à une température comprise entre 40 et 45 C, puis l' émulsion est lissée à vitesse importante pendant 3 à 5 minutes: Le procédé de préparation final est caractérisé en ce que les principes actifs, le parfum et le colorant sont additionnés à l'émulsion de type H/E par-agitation "variante" pendant 5 à<B>10</B> minutes, le PH étant maintenu à 7 t 0,5.The preparation process is characterized in that the HlE type emulsion is prepared according to the following method. The fatty phase and the aqueous phase previously prepared are heated separately to a temperature ranging between 80 and 90.degree. C., and then after stirring the phase. In the aqueous phase, the fatty phase is slowly incorporated in the aqueous phase. Stirring is continued until a temperature of between 40 and 45 ° C. is reached. The emulsion is then smoothed at a high speed for 3 to 5 minutes. characterized in that the active ingredients, the perfume and the dye are added to the "variant" O / W emulsion for 5 to <B> 10 </ B> minutes, the pH being maintained at 7 t 0.5.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0006472A FR2802421A1 (en) | 1999-12-17 | 2000-05-19 | Cosmetic oil-in-water emulsion creams containing aqueous placenta extract for the treatment of heat-sensitive skin |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9915944A FR2802412A1 (en) | 1999-12-17 | 1999-12-17 | Cosmetic oil-in-water emulsion creams containing aqueous placentary extract for the treatment of heat-sensitive skin |
FR0006472A FR2802421A1 (en) | 1999-12-17 | 2000-05-19 | Cosmetic oil-in-water emulsion creams containing aqueous placenta extract for the treatment of heat-sensitive skin |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2802421A1 true FR2802421A1 (en) | 2001-06-22 |
Family
ID=26212414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0006472A Pending FR2802421A1 (en) | 1999-12-17 | 2000-05-19 | Cosmetic oil-in-water emulsion creams containing aqueous placenta extract for the treatment of heat-sensitive skin |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2802421A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1591104A1 (en) * | 2004-03-17 | 2005-11-02 | Stada Arzneimittel Ag | Use of antioxidants for the preparation of pharmaceutical or cosmetic compositions for protecting the skin from damages by infrared-radiations |
EP1591105A1 (en) * | 2004-03-17 | 2005-11-02 | Stada Arzneimittel Ag | Use of antioxidants for the preparation of pharmaceutical or cosmetic compositions for protecting the skin from damages by infrared-radiations |
FR3087337A1 (en) * | 2018-10-22 | 2020-04-24 | Thierry Haag | DERMATOLOGICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF MASTODYNIA |
-
2000
- 2000-05-19 FR FR0006472A patent/FR2802421A1/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1591104A1 (en) * | 2004-03-17 | 2005-11-02 | Stada Arzneimittel Ag | Use of antioxidants for the preparation of pharmaceutical or cosmetic compositions for protecting the skin from damages by infrared-radiations |
EP1591105A1 (en) * | 2004-03-17 | 2005-11-02 | Stada Arzneimittel Ag | Use of antioxidants for the preparation of pharmaceutical or cosmetic compositions for protecting the skin from damages by infrared-radiations |
EP2233127A1 (en) * | 2004-03-17 | 2010-09-29 | Stada Arzneimittel Ag | Use of antioxidants for the preparation of pharmaceutical or cosmetic compositions for protecting the skin from damages by infrared-radiations |
EP2233127B1 (en) | 2004-03-17 | 2020-05-27 | Stada Arzneimittel Ag | Use of antioxidants for the preparation of pharmaceutical or cosmetic compositions for protecting the skin from damages by infrared-radiations |
EP1591105B1 (en) | 2004-03-17 | 2020-05-27 | Stada Arzneimittel Ag | Use of antioxidants for the preparation of pharmaceutical or cosmetic compositions for protecting the skin from damages by infrared-radiations |
FR3087337A1 (en) * | 2018-10-22 | 2020-04-24 | Thierry Haag | DERMATOLOGICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF MASTODYNIA |
WO2020083694A1 (en) * | 2018-10-22 | 2020-04-30 | Haag Thierry | Dermatological composition intended for the prevention and/or treatment of mastodynia |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0709084B1 (en) | Use of an oil rich in petroselinic acid as hydrating agent | |
US6582710B2 (en) | Products for topical applications comprising oil bodies | |
US6599513B2 (en) | Products for topical applications comprising oil bodies | |
CA1138739A (en) | Make up remover for the face and eyes | |
JP3415198B2 (en) | External preparation for skin | |
CH648492A5 (en) | STABLE EMULSIONS OBTAINED FROM A NATURAL EMULSIFYING AGENT STABILIZED BY ALOE SUC. | |
FR2751537A1 (en) | USE OF HONEY AS A KERATOLYTIC AGENT, IN PARTICULAR FOR IMPROVING SKIN DYE SKIN AND TREATING WRINKLES | |
JP2005239715A (en) | Composition of pharmaceutical cosmetic for alleviating photoaging | |
JP2009155227A (en) | Living body tissue repair promoting drug | |
FR2826579A1 (en) | COSMETIC COMPOSITION CONTAINING AT LEAST ONE OIL EXTRACTED FROM CUCURBITACEOUS SEEDS, ITS COSMETIC, THERAPEUTIC AND FOOD USE | |
RU2242216C1 (en) | Lifting-cream for dry and sensitive skin | |
US20140227204A1 (en) | Skin compositions containing hydrocortisone | |
FR2810540A1 (en) | Fluid aqueous composition for rejuvenation creams, foundations, lipsticks and baby creams comprises active ingredients dispersed in non-surfactant vegetable medium rich in phospholipids and glycolipids | |
WO2021224575A1 (en) | Cosmetic composition comprising at least one calcareous red algae | |
EP1335791B1 (en) | Stabilised cosmetic and/or dermatological composition containing a colouring agent and an emulsifier | |
KR100523540B1 (en) | Composition Inhibiting Activity of 5α-Reductase and Antimicrobial Activity to Propionibacterium Acnes | |
FR2802421A1 (en) | Cosmetic oil-in-water emulsion creams containing aqueous placenta extract for the treatment of heat-sensitive skin | |
JP2971549B2 (en) | Cosmetics | |
Kala et al. | Formulation and invitro evaluation of poly herbal anti aging face cream | |
FR3091162A1 (en) | Cosmetic and / or nutraceutical use of a bark extract of Eperua falcata | |
JPS6092204A (en) | Cosmetic | |
FR3001634A1 (en) | USE OF ORANGE ESSENTIAL OIL TO TREAT SKIN PIGMENTATION DISORDERS | |
JP2005194252A (en) | Fat accumulation-suppressing composition | |
JPH11158053A (en) | Cosmetic | |
FR2802412A1 (en) | Cosmetic oil-in-water emulsion creams containing aqueous placentary extract for the treatment of heat-sensitive skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CA | Change of address |